These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12444107)

  • 41. Wnt signaling pathway involvement in genotypic and phenotypic variations in Waardenburg syndrome type 2 with MITF mutations.
    Wang XP; Liu YL; Mei LY; He CF; Niu ZJ; Sun J; Zhao YL; Feng Y; Zhang H
    J Hum Genet; 2018 May; 63(5):639-646. PubMed ID: 29531335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical classification and genetic mutation study of two pedigrees with type II Waardenburg syndrome].
    Chen Y; Yang F; Zheng H; Zhu G; Hu P; Wu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):810-3. PubMed ID: 26663054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locus and allelic heterogeneity and phenotypic variability in Waardenburg syndrome.
    Somashekar PH; Girisha KM; Nampoothiri S; Gowrishankar K; Devi RR; Gupta N; Narayanan DL; Kaur A; Bajaj S; Jagadeesh S; Lewis LES; Shailaja S; Shukla A
    Clin Genet; 2019 Mar; 95(3):398-402. PubMed ID: 30394532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelomeningocele and Waardenburg syndrome (type 3) in patients with interstitial deletions of 2q35 and the PAX3 gene: possible digenic inheritance of a neural tube defect.
    Nye JS; Balkin N; Lucas H; Knepper PA; McLone DG; Charrow J
    Am J Med Genet; 1998 Feb; 75(4):401-8. PubMed ID: 9482647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene.
    Jacquemin P; Lannoy VJ; O'Sullivan J; Read A; Lemaigre FP; Rousseau GG
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1200-5. PubMed ID: 11478782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SLUG (SNAI2) overexpression in embryonic development.
    Pérez-Mancera PA; González-Herrero I; Maclean K; Turner AM; Yip MY; Sánchez-Martín M; García JL; Robledo C; Flores T; Gutiérrez-Adán A; Pintado B; Sánchez-García I
    Cytogenet Genome Res; 2006; 114(1):24-9. PubMed ID: 16717446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical and genetic investigation of families with Waardenburg syndrome type 2].
    Chen HS; Liao XB; Liu YL; He CF; Zhang H; Jiang L; Feng Y; Mei LY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1946-1949. PubMed ID: 29798271
    [No Abstract]   [Full Text] [Related]  

  • 48. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse.
    Tassabehji M; Newton VE; Leverton K; Turnbull K; Seemanova E; Kunze J; Sperling K; Strachan T; Read AP
    Hum Mol Genet; 1994 Jul; 3(7):1069-74. PubMed ID: 7981674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform.
    Hershey CL; Fisher DE
    Gene; 2005 Feb; 347(1):73-82. PubMed ID: 15715979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF.
    Smith SD; Kelley PM; Kenyon JB; Hoover D
    J Med Genet; 2000 Jun; 37(6):446-8. PubMed ID: 10851256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2.
    Tassabehji M; Read AP; Newton VE; Patton M; Gruss P; Harris R; Strachan T
    Nat Genet; 1993 Jan; 3(1):26-30. PubMed ID: 8490648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
    Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
    Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homozygosity for Waardenburg syndrome.
    Zlotogora J; Lerer I; Bar-David S; Ergaz Z; Abeliovich D
    Am J Hum Genet; 1995 May; 56(5):1173-8. PubMed ID: 7726174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melanocytes and the microphthalmia transcription factor network.
    Steingrímsson E; Copeland NG; Jenkins NA
    Annu Rev Genet; 2004; 38():365-411. PubMed ID: 15568981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of the SLUG (SNAI2) gene results in human piebaldism.
    Sánchez-Martín M; Pérez-Losada J; Rodríguez-García A; González-Sánchez B; Korf BR; Kuster W; Moss C; Spritz RA; Sánchez-García I
    Am J Med Genet A; 2003 Oct; 122A(2):125-32. PubMed ID: 12955764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Regulatory network of transcription factor MITF in pigment cells].
    Takeda K
    Seikagaku; 2003 Nov; 75(11):1444-8. PubMed ID: 14699845
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of the mutant microphthalmia-associated transcription factor found in Tietz syndrome on the in vitro development of mast cells.
    Shigemura T; Shiohara M; Tanaka M; Takeuchi K; Koike K
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):442-7. PubMed ID: 20485200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cascade of genes related to Waardenburg syndrome.
    Tachibana M
    J Investig Dermatol Symp Proc; 1999 Sep; 4(2):126-9. PubMed ID: 10536986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.
    Tassabehji M; Newton VE; Read AP
    Nat Genet; 1994 Nov; 8(3):251-5. PubMed ID: 7874167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two induced pluripotent stem cell (iPSC) lines derived from patients affected by Waardenburg syndrome type 1 retain potential to activate neural crest markers.
    Alkobtawi M; Pla P; Onteniente B; Seal S; Pingault V; Marlin S; Monsoro-Burq AH
    Stem Cell Res; 2023 Jun; 69():103074. PubMed ID: 36989619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.